NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 140 filers reported holding NEKTAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $624,000 | +145.7% | 26,599 | +28.3% | 0.02% | +183.3% |
| Q4 2016 | $254,000 | -40.2% | 20,729 | -16.2% | 0.01% | -40.0% |
| Q3 2016 | $425,000 | +11.5% | 24,723 | -7.5% | 0.01% | +25.0% |
| Q2 2016 | $381,000 | +95.4% | 26,741 | +130.7% | 0.01% | +166.7% |
| Q4 2015 | $195,000 | -18.8% | 11,593 | -39.6% | 0.00% | -25.0% |
| Q2 2015 | $240,000 | +71.4% | 19,207 | +51.3% | 0.00% | +33.3% |
| Q1 2015 | $140,000 | -68.0% | 12,692 | -65.0% | 0.00% | -62.5% |
| Q3 2014 | $437,000 | +30.1% | 36,234 | +38.2% | 0.01% | +60.0% |
| Q2 2014 | $336,000 | +116.8% | 26,214 | +105.4% | 0.01% | +150.0% |
| Q1 2014 | $155,000 | -61.6% | 12,762 | -67.0% | 0.00% | -60.0% |
| Q3 2013 | $404,000 | – | 38,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |